Acta Haematologica

Papers
(The TQCC of Acta Haematologica is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany23
Role of Autologous Transplant in Newly Diagnosed Multiple Myeloma Patients Treated with Novel Triplets: A Systematic Review and Meta-Analysis19
COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response12
Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future12
Gilteritinib in Isolated Breast Relapse of <b><i>FLT3</i></b> Positive Acute Myeloid Leukemia: A Case Report and Review of Literature11
Cellular Therapy in Chronic Lymphocytic Leukemia: Have We Advanced in the Last Decade?11
Prognostic Markers in the Era of Targeted Therapies11
Machine Learning for the Prediction of Survival Post-Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience10
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell Transplantation10
Bortezomib and Vorinostat Therapy as Maintenance Therapy Post-Autologous Transplant for Non-Hodgkin’s Lymphoma Using R-BEAM or BEAM Transplant Conditioning Regimen9
Challenges and Management of Long COVID in Individuals with Hematological Illnesses8
A Novel ANK1 Mutation in a Neonatal Hereditary Spherocytosis Case: Diagnostic Challenges and Familial Genetic Analysis8
A Rare Clinical Case of Secondary Central Nervous System Involvement without Transformation in Hairy Cell Leukemia: A Case Report and Literature Review8
High Rates of Anti-αIIbβ3 Antibodies Produced by a Glanzmann Thrombasthenia Patient after First and Unique Red Blood Cells Administration8
Momelotinib bei Myelofibrose und Anämie6
Contents Vol. 146, 20236
Front & Back Matter6
Two Novel Heterozygous Mutations (p.γPhe230Val and p.AαAsn839Thr) Cause Hereditary Hypodysfibrinogenemia in Two Chinese Independent Families6
PharmaNews6
Acute Promyelocytic Leukemia with del(6)(p22) and Atypical bcr2 PML::RARA Fusion Transcript: A Case Report6
Comprehensive Morphological Assessment of Cord Blood: Normal Values and the Prevalence of Morphologically Aberrant Leukocytes6
Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient5
Complete Response to Donor Lymphocyte Infusion for Primary Hemophagocytic Lymphohistiocytosis Relapse after Allogeneic Hematopoietic Cell Transplantation5
The Recurrent Atypical e8a2 BCR::ABL1 Transcript with Insertion of an Inverted 55 Base Pair ABL1 Intron 1b Sequence: A Detailed Molecular Analysis5
A prognostic survival model based on endocrine-related gene expression in acute myelogenous leukemia5
Health-Related Complications during Follow-Up and Their Impact on Blood Cancer Survivors: Results from the “Aftercare in Blood Cancer Survivors” (ABC) Study5
Splenic Micronodular T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: The Corticosteroid Pretreatment Hypothesis5
In Memoriam: Isaac Ben-Bassat (1937–2023) A Lifelong Legacy in Hematology5
Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia according to First-Line Intravenous Immunoglobulin Response5
Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma5
Adverse Effects of COVID-19 Vaccination in Patients with Transfusion-Dependent Thalassemia: An Observational Study from a Tertiary Care Center in Punjab, India5
Tanshinone IIA Inhibits Tissue Factor Expression Induced by Thrombin in Human Umbilical Vein Endothelial Cells via PAR-1 and p38 MAPK Signaling Pathway4
Leg Ulcers: A Report in Patients with Hemoglobin E Beta Thalassemia and Review of the Literature in Severe Beta Thalassemia4
Vaccination for SARS-CoV-2 in Hematological Patients4
Untangling Complexities of Acute Myeloid Leukemia Review Series4
Treatment-Free Remission in Real-World Chronic Myeloid Leukemia Patients: Insights from German Hematology Practices4
Macrocytosis in Mitochondrial DNA Deletion Syndromes4
Hematological evaluation and management of menorrhagia in adolescents: Lessons from adolescent heavy menstrual bleeding clinics4
Utility of Galactomannan Screening for Early Detection of Invasive Aspergillosis in High-Risk Hemato-Oncology Patients4
Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia4
Clinical Outcomes, Survival, and Predictors in Lower-Risk Myelodysplastic Syndrome Patients Treated with Cyclosporine A4
Real-World Risk of Severe Cytopenias in Multiple Myeloma Patients Sequentially Treated with Immunomodulatory Drugs4
Racial and Ethnic Characteristics and Outcomes of Patients Diagnosed with CLL/SLL in the USA4
Consensus-Based Expert Recommendations on the Management of Hemophilia A in the Gulf Region4
Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study4
The IRE1α Endonuclease Plays a Dual Role in Regulating the XBP1/miRNA-34a Axis and PD-1 Expression within Natural Killer Cells in Hodgkin Lymphoma4
Clinical Challenges in Treating Cancer Associated Thrombosis: A Clinically Oriented Review3
Real-World Use of Ruxolitinib in Patients with Myelofibrosis and Anemia or Thrombocytopenia at Diagnosis3
False-Negative Testing for FIP1L1::PDGFRA by Fluorescence in situ Hybridization Is a Frequent Cause of Diagnostic Delay3
Front & Back Matter3
A Case of Recurrent Localized Pulmonary Nodular Light Chain Amyloidosis Treated with Daratumumab plus CyBorD3
Acute Promyelocytic Leukemia Presenting with Cranial Nerve Involvement and Clivus Mass3
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment3
Timing of Initiation of Calcineurin Inhibitors in Pediatric Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: Effects on Survival, Relapse, and Cytokine Release Syndrome3
RESULTS OF LONG-TERM THERAPY WITH A BIOSIMILAR OF ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA3
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell Transplantation3
Sustained Response to Ruxolitinib of Eosinophilia-Associated Myeloproliferative Neoplasm with Translocation t(8;9)(p21;p24)3
Adult Acute Myeloid Leukemia with the <b><i>KMT2A-</i></b>Mixed Lineage Leukemia <b><i>T10</i></b> Fusion: An Analysis of 10 Cases Showed Common Feature3
Cytomegalovirus Reactivation during Elotuzumab Therapy in Patients with Multiple Myeloma2
The Effectiveness of the Intermediate and Therapeutic Doses of Enoxaparin in COVID-19 Patients: A Comparative Study of Factor Xa Inhibition2
Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine2
Contents Vol. 145, 20222
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa2
Evaluation of Activated Carbon Treatment on Overcoming the Interference of Rivaroxaban on the Detection of Functional Lupus Anticoagulant2
Shikonin Exerts an Antileukemia Effect against FLT3-ITD Mutated Acute Myeloid Leukemia Cells via Targeting FLT3 and Its Downstream Pathways2
Direct STAT3 and STAT5 Inhibition Overcomes Treatment Resistance in a Murine Derived In Vitro Model of Acute Lymphoblastic Leukaemia driven by ETV6::JAK22
ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon alfa-2b-njft in Polycythemia Vera2
Impact of COVID-19 on Patients with Beta-Thalassemia Major: An Observational Study2
Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients2
TES and SLC40A1 as Potential Biomarkers for Predicting Survival in T-Cell Acute Lymphoblastic Leukemia2
Glomerulonephritis Secondary to Acute Promyelocytic Leukemia that Resolved after Induction Therapy2
Acknowledgement to Reviewers2
Expression of Programmed Cell Death-1 and Programmed Cell Death Ligands in Nodal Peripheral T-Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance2
PharmaNews2
Chemotherapy or Allogeneic Stem Cell Transplantation as Salvage Therapy for Patients with Refractory Acute Myeloid Leukemia: A Multicenter Analysis2
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Blood Safety2
Clinical Significance of Plasma Epstein-Barr Virus DNA in Peripheral T-Cell Lymphomas2
Inflammatory factors and immune cells in relation to multiple myeloma2
DRESS is not a rare complication during the initial treatment of newly diagnosed multiple myeloma_the experience of two medical institutes2
Relapse Primary Central Nervous System Lymphoma Successfully Consolidated with Allogeneic Stem Cell Transplantation with Thiotepa/Busulfan/Fludarabine Conditioning2
Tumor Lysis Syndrome Is Associated with Worse Outcomes in Adult Patients with Acute Lymphoblastic Leukemia2
Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes2
Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm2
Monitoring Minimal Residual Disease in <b><i>RUNX1</i></b>-Mutated Acute Myeloid Leukemia2
Myeloid Neoplasm with <b><i>PCM1-PDGFRB</i></b> Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review2
Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype2
Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk2
Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient2
Coronary Artery Disease and Microvascular Ischemia in Patients with Cardiac Amyloidosis2
Impact of Prophylactic Antibacterials on Coagulation Profiles and Bleeding in Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome2
Outcome and Prognostic Factors of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory ETV6/RUNX1-Positive Acute Lymphoblastic Leukemia2
0.22408199310303